Cancer Patients With Diabetes May Have Worse Outcomes on ICIs
Cancer patients with type 2 diabetes may have worse survival outcomes on immune checkpoint inhibitor therapy, a new study suggests.
Cancer patients with type 2 diabetes may have worse survival outcomes on immune checkpoint inhibitor therapy, a new study suggests.
As many as 1 in 4 patients receiving treatment for cancer and HIV may be at risk of experiencing drug-drug interactions, according to researchers.
In an oral presentation at the 2023 ONA Summit, a thoracic oncology nurse practitioner reviewed the advances in the treatment of NSCLC and management of related adverse effects.
Vast majority of cancers diagnosed due to symptoms or other medical care.
Risk for incident lung cancer increased for current smokers and former smokers not recommended for annual low-dose CT screening
Risk for CVD, heart failure, and stroke significantly increased after adjustment for cardiovascular risk factors.
The approach improved risk assessment compared with 2021 USPSTF screening criteria.
This review provides a concise overview of the epidemiology, etiology, history, diagnostic criteria, and management of small cell lung cancer.
An update on the available cancer screening guidelines, benefits/limitations, and risks for cervical, breast, prostate, colon, and lung cancers.
A detailed smoking history may help to inform patient outcomes.